This contrasts with the pattern seen when p53 deficient samples are compared with p53 proficient samples (Supplementary Fig. 7b), and does not support a role for BRG1 loss leading to aneuploidy tolerance in colorectal cancer. Here, SMARCA4 is linked to colorectal cancer.